Evidence map›Paper›PMID 33382949›Full record

ArticlemAbs

Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments.

Francesco Nannini, Lenart Senicar, Farhaan Parekh, Khai J Kong, Alexander Kinna, Reyisa Bughda, James Sillibourne, Xihao Hu, Biao Ma, Yuchen Bai and 3 more

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Whole-genome sequencing ofMicrobiology resource announcements · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Selection of Affibody Affinity Proteins from Phagemid Libraries.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  10. Article
  11. Review
  12. Reconstruction of full antibody sequences in NGS datasets and accurate VComputational and structural biotechnology journal · 2022
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Francesco NanniniCancer Institute, University College London , London, UK.ORCID 0000-0001-9589-5107
Lenart SenicarAutolus Therapeutics , London, UK.
Farhaan ParekhCancer Institute, University College London , London, UK.
Khai J KongCancer Institute, University College London , London, UK.
Alexander KinnaAutolus Therapeutics , London, UK.
Reyisa BughdaAutolus Therapeutics , London, UK.
James SillibourneAutolus Therapeutics , London, UK.
Xihao HuGV20 Therapeutics LLC , Cambridge, MA, USA.
Biao MaAutolus Therapeutics , London, UK.
Yuchen BaiAutolus Therapeutics , London, UK.
Mathieu FerrariAutolus Therapeutics , London, UK.
Martin A PuleCancer Institute, University College London , London, UK.
Shimobi C OnuohaAutolus Therapeutics , London, UK.
Autolus (United Kingdom) · GBUniversity College London · GBGV20 Therapeutics (United States)

Funding

Cancer Research UK 17658
6 · The paper itself

Abstract

Phage display technology in combination with next-generation sequencing (NGS) currently is a state-of-the-art method for the enrichment and isolation of monoclonal antibodies from diverse libraries. However, the current NGS methods employed for sequencing phage display libraries are limited by the short contiguous read lengths associated with second-generation sequencing platforms. Consequently, the identification of antibody sequences has conventionally been restricted to individual antibody domains or to the analysis of single domain binding moieties such as camelid VHH or cartilaginous fish IgNAR antibodies. In this study, we report the application of third-generation sequencing to address this limitation. We used single molecule real time (SMRT) sequencing coupled with hairpin adaptor loop ligation to facilitate the accurate interrogation of full-length single-chain Fv (scFv) libraries. Our method facilitated the rapid isolation and testing of scFv antibodies enriched from phage display libraries within days following panning. Two libraries against CD160 and CD123 were panned and monitored by NGS. Analysis of NGS antibody data sets led to the isolation of several functional scFv antibodies that were not identified by conventional panning and screening strategies. Our approach, which combines phage display selection of immune libraries with the full-length interrogation of scFv fragments, is an easy method to discover functional antibodies, with a range of affinities and biophysical characteristics.

Indexed as

Peptide LibraryAmino Acid SequenceAnimalsAntibodies, MonoclonalAntigens, CDBayes TheoremGPI-Linked ProteinsHEK293 CellsHigh-Throughput Nucleotide SequencingHumansInterleukin-3 Receptor alpha SubunitRatsRats, WistarReceptors, ImmunologicSingle-Chain AntibodiesAntibodies, MonoclonalAntigens, CDCD160 protein, humanGPI-Linked ProteinsInterleukin-3 Receptor alpha SubunitPeptide LibraryReceptors, ImmunologicSingle-Chain Antibodiesaffinity modulationAntibody discoverylong-read sequencingphage displayrat immune librariesscFv antibody

Identifiers

PMID33382949
PMCPMC7781620
OpenAlexW3116262273

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.